Free Trial

Carisma Therapeutics (CARM) Institutional Ownership

Carisma Therapeutics logo
$0.40 -0.01 (-1.99%)
Closing price 04:00 PM Eastern
Extended Trading
$0.40 +0.01 (+1.27%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Carisma Therapeutics (NASDAQ:CARM)

Current
Institutional Ownership
Percentage
44.27%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$1.24M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$1.09M
Get CARM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Carisma Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CARM Institutional Buying and Selling by Quarter

Carisma Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/6/2025Universal Beteiligungs und Servicegesellschaft mbH200,000$62K0.0%N/A0.479%
2/17/2025Millennium Management LLC120,157$50K0.0%-15.7%0.288%
2/13/2025Renaissance Technologies LLC231,357$97K0.0%+11.9%0.554%
11/19/2024Barclays PLC549,305$539K0.0%+3,661,933.3%1.316%
11/16/2024Geode Capital Management LLC259,184$254K0.0%-8.5%0.621%
11/15/2024Barclays PLC549,305$539K0.0%+3,661,933.3%1.316%
11/15/2024Wexford Capital LP34,861$34K0.0%+75.5%0.083%
9/16/2024Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063%
8/15/2024Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063%
8/15/2024TPG GP A LLC842,031$1.28M0.0%-42.0%2.027%
8/9/2024Renaissance Technologies LLC139,360$212K0.0%-38.3%0.335%
5/10/2024Vanguard Group Inc.1,579,961$3.59M0.0%+0.7%3.803%
5/7/2024Empowered Funds LLC26,984$61K0.0%-43.9%0.065%
2/14/2024Trustees of The University of Pennsylvania1,252,107$3.67M10.3%-28.9%3.102%
10/13/2023SG Americas Securities LLC13,653$58K0.0%N/A0.034%
9/21/2023Barclays PLC5,312$47K0.0%N/A0.013%
8/4/2023American International Group Inc.12,834$113K0.0%N/A0.032%
7/27/2023EA Series Trust40,434$355K0.0%N/A0.100%
6/15/2023Trustees of The University of Pennsylvania2,182,812$6.77M6.6%N/A5.422%
5/15/2023Wittenberg Investment Management Inc.46,703$145K0.1%N/A0.459%
5/12/2023Deuterium Capital Management LLC51,256$159K0.2%N/A0.504%
5/10/2023Connor Clark & Lunn Investment Management Ltd.14,796$46K0.0%N/A0.145%
5/3/2023Jump Financial LLC17,542$54K0.0%N/A0.172%
5/1/2023Virtu Financial LLC15,335$48K0.0%N/A0.151%
4/27/2023Stratos Wealth Partners LTD.19,899$62K0.0%N/A0.195%
4/24/2023Blodgett Wealth Advisors LLC29,660$92K0.1%N/A0.291%
4/14/2023BML Capital Management LLC411,398$1.28M1.1%N/A4.041%
(Data available from 1/1/2016 forward)

CARM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CARM shares?

During the previous two years, 14 institutional investors and hedge funds held shares of Carisma Therapeutics. The most heavily invested institutionals were Trustees of The University of Pennsylvania ($3.67M), Vanguard Group Inc. ($3.59M), TPG GP A LLC ($1.28M), Barclays PLC ($539K), EA Series Trust ($355K), Geode Capital Management LLC ($254K), and American International Group Inc. ($113K).Learn more on Carisma Therapeutics' institutional investors.

What percentage of Carisma Therapeutics' stock is owned by institutional investors?

44.27% of Carisma Therapeutics' stock is owned by institutional investors. Learn more on CARM's institutional investor holdings.

Which institutional investors have been buying Carisma Therapeutics' stock?

Of the 9 institutional investors that purchased Carisma Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Barclays PLC ($1.10M), Universal Beteiligungs und Servicegesellschaft mbH ($200K), Point72 Asia Singapore Pte. Ltd. ($52.01K), EA Series Trust ($40.43K), Renaissance Technologies LLC ($24.60K), Wexford Capital LP ($15K), and SG Americas Securities LLC ($13.65K).

How much institutional buying is happening at Carisma Therapeutics?

Institutional investors have bought a total of 1,390,192 shares in the last 24 months. This purchase volume represents approximately $1.24M in transactions.

Which of Carisma Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Carisma Therapeutics stock in the last 24 months: TPG GP A LLC ($609.85K), Renaissance Technologies LLC ($86.64K), Geode Capital Management LLC ($24.22K), and Millennium Management LLC ($22.37K).

How much institutional selling is happening at Carisma Therapeutics?

Institutional investors have sold a total of 743,074 shares in the last 24 months. This volume of shares sold represents approximately $1.09M in transactions.



This page (NASDAQ:CARM) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners